Free Trial

107,809 Shares in Mobia Medical, Inc. $MOBI Acquired by University of Texas Texas AM Investment Management Co.

Mobia Medical logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • University of Texas Texas AM Investment Management Co. acquired 107,809 Mobia Medical shares in the third quarter, worth about $1.02 million and representing roughly 0.32% of the company.
  • Mobia reported quarterly revenue of $15.62 million, up 73.3% year over year, but its loss of $0.52 per share was wider than analysts’ $0.46 estimate.
  • Analysts’ consensus rating is Moderate Buy, with a $21 average price target; recent ratings include a $20 target from BTIG and a $17 target from JPMorgan.
  • Five stocks to consider instead of Mobia Medical.

University of Texas Texas AM Investment Management Co. acquired a new stake in shares of Mobia Medical, Inc. (NASDAQ:MOBI - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 107,809 shares of the company's stock, valued at approximately $1,019,000. University of Texas Texas AM Investment Management Co. owned approximately 0.32% of Mobia Medical as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp bought a new position in shares of Mobia Medical in the 2nd quarter worth $735,000. Citadel Advisors LLC acquired a new stake in Mobia Medical in the 2nd quarter valued at $670,000. Finally, Readystate Asset Management LP acquired a new stake in Mobia Medical in the 2nd quarter valued at $134,000.

Mobia Medical Stock Performance

MOBI stock opened at $11.19 on Monday. The company has a debt-to-equity ratio of 0.05, a current ratio of 11.79 and a quick ratio of 11.24. The company's 50-day moving average is $10.00. The firm has a market cap of $372.52 million and a P/E ratio of -0.55. Mobia Medical, Inc. has a 52-week low of $8.03 and a 52-week high of $15.29.

Mobia Medical (NASDAQ:MOBI - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.46) by ($0.06). The company had revenue of $15.62 million during the quarter. Mobia Medical had a negative return on equity of 2,198.27% and a negative net margin of 135.03%. Mobia Medical's quarterly revenue was up 73.3% compared to the same quarter last year. As a group, sell-side analysts forecast that Mobia Medical, Inc. will post -2.63 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Casey Tansey purchased 35,572 shares of the firm's stock in a transaction that occurred on Thursday, August 13th. The stock was acquired at an average price of $11.51 per share, for a total transaction of $409,433.72. Following the completion of the acquisition, the director owned 268,904 shares of the company's stock, valued at $3,095,085.04. This represents a 15.25% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders purchased a total of 87,000 shares of company stock worth $1,016,367 over the last 90 days.

Analyst Upgrades and Downgrades

A number of brokerages have commented on MOBI. JPMorgan Chase & Co. boosted their price target on shares of Mobia Medical from $15.00 to $17.00 and gave the company an "overweight" rating in a research note on Wednesday, August 12th. Weiss Ratings initiated coverage on shares of Mobia Medical in a research note on Wednesday, August 12th. They issued a "sell (e-)" rating on the stock. Finally, BTIG Research reiterated a "buy" rating and set a $20.00 price objective on shares of Mobia Medical in a report on Friday. Five research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, Mobia Medical has a consensus rating of "Moderate Buy" and a consensus target price of $21.00.

Check Out Our Latest Stock Analysis on Mobia Medical

Mobia Medical Company Profile

(Free Report)

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Mobia Medical Right Now?

Before you consider Mobia Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mobia Medical wasn't on the list.

While Mobia Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines